NYSE:GMED - New York Stock Exchange, Inc. - US3795772082 - Common Stock - Currency: USD
TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 2.51B | 2.52B | 1.57B | 1.02B | 958.10M | |||
Cost Of Goods | 989.35M | 1.04B | 548.17M | 263.70M | 239.20M | |||
Gross Profit | 1.52B | 1.48B | 1.02B | 759.10M | 718.90M | |||
Operating Expenses | 1.23B | 1.26B | 818.45M | 522.90M | 524.00M | |||
Research and Development | 138.82M | 161.60M | 124.01M | 73.00M | 97.30M | |||
Selling, General, and Administrative Expenses | 974.74M | 977.48M | 643.41M | 432.10M | 408.10M | |||
Operating Income | 289.40M | 225.61M | 201.85M | 236.30M | 194.90M | |||
Interest Income/Expense | -24.26M | -47.47M | 34.39M | 13.20M | 7.90M | |||
Other Income/Expense | 2.21M | 2.21M | -2.14M | 1.90M | 600.00K | |||
Non Recurring Items | -34.40M | -59.62M | -68.71M | -8.30M | -22.90M | |||
Income Before Taxes | 232.95M | 120.72M | 165.39M | 243.00M | 180.40M | |||
Income Tax | 47.38M | 17.74M | 42.52M | 52.90M | 31.20M | |||
Net Income | 185.56M | 102.98M | 122.87M | 190.20M | 149.20M | |||
EBITDA | 554.23M | 479.63M | 346.58M | 304.60M | 264.80M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | 1.34 | 0.75 | 1.07 | 1.85 | 1.44 | |||
Non GAAP EPS | 3.10 | 3.14 | 2.33 | 2.07 | 2.04 | |||
Statistics | ||||||||
Gross Profit Margin | 60.60% | 58.91% | 65.05% | 74.22% | 75.03% | |||
Profit Margin | 7.39% | 4.09% | 7.83% | 18.60% | 15.57% | |||
Operating Profit Margin | 11.53% | 8.95% | 12.87% | 23.10% | 20.34% |
All data in USD